On Monday, CorMedix Inc (NASDAQ: CRMD) was 3.18% up from the session before settling in for the closing price of $6.91. A 52-week range for CRMD has been $3.61 – $13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -40.30% over the past five years. When this article was written, the company’s average yearly earnings per share was at 328.57%. With a float of $59.59 million, this company’s outstanding shares have now reached $64.41 million.
Let’s look at the performance matrix of the company that is accounted for 65 employees. In terms of profitability, gross margin is 92.66%, operating margin of -51.43%, and the pretax margin is -44.45%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CorMedix Inc stocks. The insider ownership of CorMedix Inc is 8.59%, while institutional ownership is 35.13%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 328.57% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
You can see what CorMedix Inc (CRMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit 0.25 in the next quarter and is forecasted to reach 1.35 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 1.86 million, a positive change from its year-to-date volume of 1.46 million. As of the previous 9 days, the stock’s Stochastic %D was 64.45%. Additionally, its Average True Range was 0.65.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 20.43%, which indicates a significant decrease from 72.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.63% in the past 14 days, which was lower than the 95.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.27, while its 200-day Moving Average is $8.40. Nevertheless, the first resistance level for the watch stands at $7.24 in the near term. At $7.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.56. If the price goes on to break the first support level at $6.93, it is likely to go to the next support level at $6.72. The third support level lies at $6.61 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are 65,182K outstanding shares of the company, which has a market capitalization of 464.73 million. As of now, sales total 43,470 K while income totals -17,930 K. Its latest quarter income was 31,210 K while its last quarter net income were 13,460 K.
